Justin Zenanko Was Featured As A Keynote Speaker At The Health 2.0 Conference
Discover How Justin Zenanko Is Driving Change Through Healthcare Innovation!
Las Vegas, USA – July 08, 2025 — The Spring 2025 Edition of the Health 2.0 Conference, hosted from March 4–6 at the Bellagio Hotel & Casino, Las Vegas, brought together global healthcare leaders dedicated to advancing innovation, patient outcomes, and clinical transformation. One of the standout keynotes was delivered by Justin Zenanko, CEO & Founder of SynerFuse, who presented a compelling perspective on how leadership, capital, and execution work together to drive meaningful change in healthcare.
Justin Zenanko, CPA, is a seasoned professional with extensive corporate finance and entrepreneurship expertise. He has held key leadership roles, including Director, Senior Vice President of Corporate Development, Vice President of Finance, and Chief Financial Officer at Recombinetics, Inc. Currently, Justin applies his experience and dedication at SynerFuse™, working to address the opioid crisis through an innovative procedure integrating spinal fusion and neuromodulation to alleviate post-operative lower back pain. He has also earned a Bachelor of Arts in Accounting and Economics, with a focus on finance and marketing, from Simpson College, and a Master of Divinity from Crown College.
In his keynote titled “Leadership + Capital + Execution = Innovation,” Justin Zenanko outlined how breakthrough ideas move from concept to clinical impact through a focused combination of leadership, investment, and execution. Drawing from history and his entrepreneurial journey, he introduced a novel intraoperative spinal stimulation approach that addresses pain during surgery, helping spinal fusion patients recover faster with reduced reliance on opioids. He shared real-world results, including cases where patients returned to work, regained mobility, and resumed their daily routines, highlighting how procedural innovation can directly improve quality of life.
Justin was also one of the panelists in the discussion titled “From Idea To Market: Navigating The Startup Journey In Healthcare And Wellness,” where he shared insights from his startup experience. He emphasized that transforming a healthcare idea into a viable solution requires leadership grounded in patient needs, capital aligned with long-term objectives, and disciplined execution. Reflecting on early clinical development, he emphasized the importance of designing for real-world outcomes, such as opioid reduction and faster recovery. He encouraged innovators to stay outcome-focused and build cross-disciplinary teams that deliver measurable patient impact.
Justin Zenanko’s presence at the health summit in Las Vegas underscored the importance of leadership and innovation in addressing today’s healthcare challenges. His insights highlighted how bold thinking and practical execution can tackle issues like opioid dependency. By sharing his journey and the impact of intraoperative stimulation, he encouraged attendees to reconsider how startups can deliver meaningful and measurable outcomes.
About Health 2.0 Conference
The Health 2.0 Conference gathers global experts in healthcare, wellness, and technology to explore innovations transforming patient care. Through keynotes, panels, and networking, it drives collaboration across AI, digital health, and the pharmaceutical industry. Hosted as a 3-day health summit in Dubai and Las Vegas, it advances the future of healthcare. To learn more, visit www.health2conf.com.
